Home > Insider Trading > Filing (0001209191-21-044563)

Filing Details

Accession Number:: 0001209191-21-044563
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-07-01 18:32:03
Reporting Period:: 2021-06-29

Accepted Time:: 2021-07-01 18:32:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1806310	Taysha Gene Therapies Inc.	TSHA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1679129	Suyash Prasad	C/O Taysha Gene Therapies, Inc. 2280 Inwood Road Dallas TX 75235	Cmo And Head Of R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-06-29	35,056	$23.74	637,533	No	4	S	Direct
Common Stock	Disposition	2021-06-29	3,862	$24.46	633,671	No	4	S	Direct
Common Stock	Disposition	2021-06-29	300	$25.19	633,371	No	4	S	Direct
Common Stock	Disposition	2021-06-30	13,374	$21.42	619,997	No	4	S	Direct
Common Stock	Disposition	2021-06-30	6,202	$22.44	613,795	No	4	S	Direct
Common Stock	Disposition	2021-06-30	500	$23.70	613,295	No	4	S	Direct
Common Stock	Disposition	2021-07-01	19,706	$21.12	593,589	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 represents shares required to be sold by the Reporting Person to satisfy tax withholding obligations in connection with the settlement of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.04 to$24.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5), (6), (7) and (8).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.04 to $24.95, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.06 to $25.44, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.13 to $22.11, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.15 to $23.11, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.16 to $24.00, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.81 to $21.53, inclusive.